Search

Your search keyword '"Audenaert, K."' showing total 690 results

Search Constraints

Start Over You searched for: Author "Audenaert, K." Remove constraint Author: "Audenaert, K."
690 results on '"Audenaert, K."'

Search Results

401. Senescent changes in cerebrospinal fluid circulatory physiology and their role in the pathogenesis of normal-tension glaucoma.

402. Abscisic Acid Promotes Susceptibility to the Rice Leaf Blight Pathogen Xanthomonas oryzae pv oryzae by Suppressing Salicylic Acid-Mediated Defenses.

403. Human exposure to mycotoxins and their masked forms through cereal-based foods in Belgium.

405. Brainpeps: the blood-brain barrier peptide database.

406. Phylogeography and virulence structure of the powdery mildew population on its 'new' host triticale.

407. Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.

408. Influence of mycotoxins and a mycotoxin adsorbing agent on the oral bioavailability of commonly used antibiotics in pigs.

409. Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder.

410. Neuro-imaging the serotonin 2A receptor as a valid biomarker for canine behavioural disorders.

411. Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: a hypothesis.

412. Are intracranial pressure fluctuations important in glaucoma?

413. Predatory violence aiming at relief in a case of mass murder: Meloy's criteria for applied forensic practice.

414. The use of hypnosedative drugs in a university hospital: has anything changed in 10 years?

415. Single photon emission computed tomography (SPECT) imaging of the dopamine transporter in healthy dogs.

416. Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer's Disease Therapy.

417. Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease.

418. Two-year outcome of vagus nerve stimulation in treatment-resistant depression.

419. Alzheimer's disease: cerebral glaucoma?

420. Hydrogen peroxide induced by the fungicide prothioconazole triggers deoxynivalenol (DON) production by Fusarium graminearum.

421. High occurrence rate of glaucoma among patients with normal pressure hydrocephalus.

422. The functional neuroanatomy of mental pain in depression.

423. Diversity of lactic acid bacteria from modified atmosphere packaged sliced cooked meat products at sell-by date assessed by PCR-denaturing gradient gel electrophoresis.

424. Quetiapine treatment and improved cognitive functioning in borderline personality disorder.

425. Alzheimer's disease and glaucoma: is there a causal relationship?

426. More advanced Alzheimer's disease may be associated with a decrease in cerebrospinal fluid pressure.

427. Regional brain perfusion in epileptic dogs evaluated by technetium-99m-ethyl cysteinate dimer SPECT.

428. Is the geriatric depression scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment?

429. The Valsalva maneuver and Alzheimer's disease: is there a link?

430. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].

431. Sociodemographic and psychopathological risk factors for repetition of attempted suicide: a 5-year follow-up study.

432. Evaluation of serotonin-2A receptor occupancy with 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain.

433. An abnormal high trans-lamina cribrosa pressure difference: a missing link between Alzheimer's disease and glaucoma?

434. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.

435. Nuclear medicine and large animal studies in the pharmacological development of psychotropics.

436. Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure.

437. [The effects of energy drinks on cognitive performance].

438. Brain activation associated with deep brain stimulation causing dissociation in a patient with Tourette's syndrome.

439. [The syndrome of Cotard: an overview].

440. Does regional brain perfusion correlate with eating disorder symptoms in anorexia and bulimia nervosa patients?

441. Differences of cortical 5-HT2A receptor binding index with SPECT in subtypes of anorexia nervosa: relationship with personality traits?

442. Resistance to Botrytis cinerea in sitiens, an abscisic acid-deficient tomato mutant, involves timely production of hydrogen peroxide and cell wall modifications in the epidermis.

443. 5-HT2A: its role in frontally mediated executive function and related psychopathology.

444. Discriminating States: the quantum Chernoff bound.

445. Serotonin transporter and dopamine transporter imaging in the canine brain.

446. Functional imaging, serotonin and the suicidal brain.

447. [Information about electroconvulsive therapy on the internet].

448. Olanzapine in Gilles de la Tourette syndrome: beyond tics.

449. Suicide among adolescents. A psychological autopsy study of psychiatric, psychosocial and personality-related risk factors.

450. Functional neuroimaging endpoints in drug development.

Catalog

Books, media, physical & digital resources